Viewing nowRisendro Tablets 35 mg (Risendronic Acid Sodium 2.5 Hydrate)
Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Dongkwang Pharmaceutical Co., Ltd.

MFDS item code 200713915 · Notified 2007.12.31 · Insurance code 645903560
Treatment and prevention of postmenopausal osteoporosis; treatment of osteoporosis in men
This medication is used for the treatment and prevention of osteoporosis in postmenopausal women, as well as for the treatment of osteoporosis in men. Osteoporosis is a condition where the strength of bones decreases, making them more prone to fractures. This medication helps improve bone density, thereby keeping bones strong. Therefore, it is effective in preventing fractures and maintaining bone health.
Adults: Administer 35 mg of risedronate sodium orally once weekly. Elderly patients (over 60 years): No dosage adjustment is necessary because the bioavailability and pharmacodynamics of this drug are similar to those in younger people. No dosage adjustment is necessary in patients with a creatinine clearance of 30 mL/min or higher. This drug is contraindicated in patients with severe renal impairment and a creatinine clearance below 30 mL/min. Food interferes with the absorption of this drug. For adequate absorption, take it at least 30 minutes before breakfast or at least 2 hours before or after consuming food or beverages at any time of day. To help the drug reach the stomach easily and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ∼ 230 mL). Taking this drug with other beverages, including mineral water, may reduce its absorption. Do not chew or suck this drug because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking it. If a patient forgets to take a dose on the scheduled day, take it the next morning when remembered. Resume the usual dosing schedule on the next scheduled day. Do not take 2 tablets on the same day.
Children under 18 years: Safety and efficacy have not been established.
This medication can irritate the gastric and esophageal mucosa, so caution should be exercised when prescribed to patients with upper gastrointestinal diseases such as gastritis, esophagitis, or ulcers. After taking the medication, do not lie down for at least 30 minutes and take it with a sufficient amount of water to reduce esophageal irritation. Patients with esophageal motility disorders, such as esophageal stricture or achalasia, those with hypocalcemia, pregnant women, or women who may become pregnant, and patients with severe renal impairment should not use this medication. This medication contains lactose, so it should not be taken by patients with lactose intolerance. During treatment, it is important to ensure adequate intake of calcium and vitamin D, and those with hypocalcemia or vitamin D deficiency should be treated before taking this medication. As a bisphosphonate, it has a rare risk of serious side effects such as osteonecrosis of the jaw or atypical femoral fractures, so patients should pay attention to oral health and consult a physician if experiencing pain in the legs. When taking this medication, avoid foods or supplements containing divalent cations (calcium, magnesium, iron, etc.) at the same time, and space out the administration by a sufficient time interval before and after taking it to ensure optimal absorption. Pregnant or breastfeeding women are advised not to take this medication, and if they are currently taking it, they should consult with a physician. Safety and efficacy have not been established for children under 18 years of age. In the case of overdose, hypocalcemia may occur; therefore, if symptoms arise, the patient should notify healthcare personnel immediately and may require calcium supplementation. This medication should be stored out of reach of children and should not be transferred to another container for safety.
Esophagitis, esophageal ulcer, esophageal erosion, esophageal obstruction, esophageal perforation, bleeding, infection, lower back pain, accidental injury, pain, abdominal pain, flu symptoms, headache, weakness, neck pain, chest pain, allergic reaction, hypertension, constipation, diarrhea, dyspepsia, nausea, peripheral edema, arthralgia, arthritis, fracture, joint abnormalities, myalgia, bone pain, dizziness, depression, insomnia, bronchitis, sinusitis, rhinitis, pharyngitis, increased coughing, rash, cataract, urinary tract infection, vomiting, uveitis, scleritis, iritis, mucocutaneous syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, Rielle syndrome, angioedema, skin reaction, osteonecrosis of the external auditory canal, jaw necrosis, liver dysfunction, jaundice, loss of appetite, asthenia, chest tightness, epigastric pain, chest discomfort, palpitations, increased sweating, facial flushing, burning sensation, kidney stones, belching, hematuria, fever, eye pain
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air from entering, and it is best kept at room temperature between 1°C and 30°C. Doing so will maintain the efficacy of the medication and prevent degradation.
Pale orange rectangular film-coated tablets
4 tablets/box [(4 tablets/PTP) × 1]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRisedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Dongkwang Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Austin Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Nexpam Korea Co., Ltd.

Risedronate Sodium 2.5 Hydrate 35mg
Tablet · Prescription medication
Hyutecs Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.2mg
Tablet · Prescription medication
Celix Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Myeongmun Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Korea United Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.